| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/19/2005 | CN1185217C Propanolamine derivatives, processes for their preparation, pharmaceuticals comprising these compounds, and their use |
| 01/19/2005 | CN1185215C Substituted glutarimides and use as IL-12 production inhibitors thereof |
| 01/19/2005 | CN1185214C Novel indeno indolone compound, its preparation method and drug composition comprising the same |
| 01/19/2005 | CN1185213C Azetidine derivatives, preparation and pharmaceutical compositions thereof |
| 01/19/2005 | CN1185211C Benzamide derivatives for the treatment of diseases resulted from cytokines |
| 01/19/2005 | CN1185210C Use of naphthalene-carboxylic acid for preparing a medicament used for treating diseases characterized by amyloid aggregation sedimentation |
| 01/19/2005 | CN1185014C Biodegradation type introducing agent of hardly water-soluble steroid, nonsteroid anti-inflammatory medicine, and its prepn. method |
| 01/19/2005 | CN1185009C Eye preparation |
| 01/19/2005 | CN1185006C Chinese medicine composition for accessory treatment of primary liver cancer and preparing method thereof |
| 01/19/2005 | CN1184989C Weight-reducing Chinese medicine acted on acupoint |
| 01/19/2005 | CN1184986C Spray for preventing and treating cold |
| 01/19/2005 | CN1184985C Tumor treating capsule and its inspecting method thereof |
| 01/19/2005 | CN1184984C Chinese-medicinal ointment for treating burn and scald and its preparing process |
| 01/19/2005 | CN1184982C Gastric and duodenum ulcer treating capsule and its preparation |
| 01/19/2005 | CN1184979C Medicine for treating diabetes and phthisis |
| 01/19/2005 | CN1184972C Composite preparation of sodium para-aminosallicylate and trimethoprim |
| 01/19/2005 | CN1184971C Pharmaceutical combination preparations |
| 01/19/2005 | CN1184970C Oral tablet containing 2-[(4-methoxy-3-methyl)-2-pyridyl]ethylsulfonyl-5-(1-H-pyrrole-1-yl)-1H-benzimidazole |
| 01/19/2005 | CN1184969C Use of unsubstituted and substituted N-(pyrrol-1-yl) pyridinamines as anticonvulsant agents |
| 01/19/2005 | CN1184968C Antibiotic compositions for treatment of the eye, ear and nose |
| 01/19/2005 | CN1184967C Tracheal smooth muscle relaxant |
| 01/19/2005 | CN1184966C compositions and methods for increasing the concentration and/or motility of spermatozoa in humans |
| 01/19/2005 | CN1184965C Remedies for osteoarthritis |
| 01/19/2005 | CN1184964C Use of carbonylamino derivatives against CNS disorders |
| 01/19/2005 | CN1184963C Bromhexine hydrochloride injection and its preparation method |
| 01/19/2005 | CN1184962C Sertraline oral condensate |
| 01/19/2005 | CN1184961C Use of EGF-R antagonists in preparing drug |
| 01/19/2005 | CN1184959C Compositions containing ascorbic acid and pectin |
| 01/19/2005 | CN1184957C Intravaginal drug delivery devices for adminsitration of testosterone and testosterone precursors |
| 01/19/2005 | CN1184931C Spine separate implant and method |
| 01/19/2005 | CN1184895C Soy compositions and their use for promoting health |
| 01/18/2005 | US6844466 Treating or preventing emphysema, cancer and dermatological disorders |
| 01/18/2005 | US6844457 Antiproliferative agents; anticancer agents; antiinflammatory agents |
| 01/18/2005 | US6844456 Administering steriods (e.g. estrogens), wherein a non-fused polycyclic, hydrophobic substituent such as adamantanyl is attached to the hydroxy-substituted A-ring thereof |
| 01/18/2005 | US6844451 Method for isolating terpene trilactones (ginkgolides, bilobalide) from leaves and pharmaceutical powders of Ginkgo biloba |
| 01/18/2005 | US6844445 Central nervous system disorders; psychological disorders |
| 01/18/2005 | US6844439 Process for the preparation of imidazole compounds |
| 01/18/2005 | US6844438 Therapy for drug abruse; side effect reduction |
| 01/18/2005 | US6844437 Chemical intermediates; anticholesterol agents, antilipemic agents |
| 01/18/2005 | US6844435 Heterocyclic compounds useful as inhibitors of tyrosine kinases |
| 01/18/2005 | US6844434 Synthesis of temozolomide and analogs |
| 01/18/2005 | US6844429 Fullerene derivative and composition comprising the same |
| 01/18/2005 | US6844423 Polypeptide for use in the diagnosis, prevention and treatment infections |
| 01/18/2005 | US6844422 Inhibitor protein of the wnt signal pathway |
| 01/18/2005 | US6844372 Crosslinked anion-exchange resin or salt thereof and phosphorus adsorbent comprising the same |
| 01/18/2005 | US6844368 Compounds useful in pain management |
| 01/18/2005 | US6844365 Using diacerein or a pharmaceutically acceptable derivative or rhein for the manufacture of a pharmaceutical formulation for the treatment of psoriasis and diseases associated therewith |
| 01/18/2005 | US6844364 Stabilization of retinoid compounds |
| 01/18/2005 | US6844363 Storage stability; drugs; influenza therapy |
| 01/18/2005 | US6844361 Pharmaceutical composition comprising a sodium hydrogen exchange inhibitor and an angiotensin converting enzyme inhibitor |
| 01/18/2005 | US6844359 As inhibitors of tumor necrosis factor; for therapy of cachexia, arthritis, rheumatoid arthritis, osteoarthritis, reperfusion injury, congestive heart failure, Crohn's disease, ulcerative colitis, systemic lupus erythrematosis |
| 01/18/2005 | US6844356 Hemorrhoid therapeutic treatment |
| 01/18/2005 | US6844354 Agent for prophylaxis and treatment of interstitial pneumonia and pulmonary fibrosis |
| 01/18/2005 | US6844352 1′-[4-[1-(4-fluorophenyl)-1H-indole-3-yl]-1-butyl]-spiro[isobenzofuran-1(3H),4′-piperidine] hydrohalogenides |
| 01/18/2005 | US6844351 Corticotropin releasing factor antagonists |
| 01/18/2005 | US6844350 Febrifugine, isofebrifugine and method for producing the same |
| 01/18/2005 | US6844349 Salt forms of E-2-methoxy-N-(3-{4-[3 methyl-4-(6-methyl-pyridin-3-yloxy)-phenylamino]-quinazolin-6-yl}-allyl)-acetamide and method of production |
| 01/18/2005 | US6844348 2,3,4-cyclopentan-2,3,4-triol-1-yl compounds |
| 01/18/2005 | US6844347 Substituted 4-amino-2aryl-pyrimidines, their production and use and pharmaceutical preparations containing same |
| 01/18/2005 | US6844345 Piperazine derivatives |
| 01/18/2005 | US6844343 N-substituted 4-aminopteridines, synthesis and use thereof as pharmaceutical agent |
| 01/18/2005 | US6844342 Heterocyclic substituted 2-methyl-benzimidazole antiviral agents |
| 01/18/2005 | US6844341 Cell cycle kinase inhibitors; such as 2-(4-(N-(2-methoxy-ethyl)-sulphamoyl)anilino)-4-(imidazo(1,2b)pyridazin-3 -yl)-pyrimidine |
| 01/18/2005 | US6844340 Tricyclic 2-pyrimidone compounds useful as HIV reverse transcriptase inhibitors |
| 01/18/2005 | US6844337 1,4-diazabicyclo[3.2.2]nonane-phenylisoxazole derivatives, their preparation and their application in therapeutics |
| 01/18/2005 | US6844336 4-fluoroalkyl-2h-benzopyrans with anti-estogenic activity |
| 01/18/2005 | US6844335 2-amino-3-(alkyl)-pyrimidone derivatives as GSK3.β.inhibitors |
| 01/18/2005 | US6844333 Reducing plaque in blood vessels using 16-methylprogesterone |
| 01/18/2005 | US6844332 (20S)-1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses |
| 01/18/2005 | US6844331 (20S)-1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses |
| 01/18/2005 | US6844330 (20S)-1α-hydroxy-2α-methyl and 2β-methyl-19-NOR-vitamin D3 and their uses |
| 01/18/2005 | US6844329 Synthetic oligo- and polysaccharides exhibiting at least one covalent bond with biotin or a biotin derivative and having the anticoagulant and antithrombotic pharmacological activities of heparin |
| 01/18/2005 | US6844328 Antiproliferative activity; low systemic toxicity; psoriasis, tumors, rheumatoid arthritis, intestinal inflammation |
| 01/18/2005 | US6844320 Treatment of preeclampsia, toxemia and preterm labor with combination of progestational agent and a nitric oxide synthase substrate and/or donor |
| 01/18/2005 | US6844318 Peptidase-cleavable, targeted antineoplastic drugs and their therapeutic use |
| 01/18/2005 | US6844313 With protein or phosphoglyceride as aqueous solution; in vitro fertilization |
| 01/18/2005 | US6844306 Water-soluble, chlorhexidine-containing compositions and use thereof |
| 01/18/2005 | US6844191 Osteogenic cell growth using a TGFβ1-von Willebrand's factor fusion protein |
| 01/18/2005 | US6844189 Chromosome 17P-linked prostate cancer susceptibility gene |
| 01/18/2005 | US6844173 Strain of Streptomyces griseus |
| 01/18/2005 | US6844153 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin |
| 01/18/2005 | US6844021 Oil or fat composition |
| 01/18/2005 | US6844014 Corn starch, zinc oxide, carboxymethylcellulose, colostrum, methylparaben, propylparaben, calendula, hypericum, aloe, glycerine, vitamin E and deionized water; relieving skin inflammation and sensitivity; nonantibiotic, nonsteroidal |
| 01/18/2005 | US6844013 Methods of stimulating the immune system |
| 01/18/2005 | US6844012 Suppressing cytokine secretion with such as sodium selenite |
| 01/18/2005 | US6844008 Tablet composition |
| 01/18/2005 | US6844007 Uniform dispersion of solubilized and microcrystalline active material without use of solubilizier; antiinflammatory, analgesic agent contained in at least isoprene-styrene block copolymer, rosin-based resin, plasticizer and menthol |
| 01/18/2005 | US6844003 Compounds derived from benzoic acid esters, composition containing said compounds and use thereof |
| 01/18/2005 | US6844001 Adjuvants and copolymer compositions |
| 01/18/2005 | US6843993 Anti-microbial-adhesion fraction derived from vaccinium |
| 01/18/2005 | US6843983 Glucocorticoid and optionally, at least one antibacterial agent, benzoyl peroxide or both as active ingredient. |
| 01/18/2005 | US6843961 Deactivation pathogens; using riboflavin sensitizers; exposure to light source |
| 01/18/2005 | US6843800 Patient temperature regulation method and apparatus |
| 01/18/2005 | US6843392 Valve with a valve stem wiper |
| 01/18/2005 | CA2367127C Macrocyclic peptides active against the hepatitis c virus |
| 01/16/2005 | WO2005000281A2 Pyrazolidinedione derivatives and their use as platelet aggregation inhibitors |
| 01/16/2005 | CA2529436A1 Pyrazolidinedione derivatives and their use as platelet aggregation inhibitors |
| 01/16/2005 | CA2465681A1 The use of conjugated linoleic acid or derivative thereof for the treatment of the common cold |
| 01/15/2005 | CA2464831A1 Stable non-dihydrate azithromycin oral suspensions |
| 01/13/2005 | WO2005003374A2 SYNTHESIS OF β-L-2-DEOXY NUCLEOSIDES |